View More View Less
  • 1 Arab Emirates University, Al Ain, United Arab Emirates
  • 2 COMSATS Institute of Information Technology, Park Road, Islamabad, Pakistan
  • 3 University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
  • 4 United Arab Emirates University, Al Ain, United Arab Emirates
  • 5 Semmelweis University, Budapest, Hungary

Distribution of K027, a hydrophilic, positively charged compound is monitored in the body of pregnant mice using high-performance liquid chromatography (HPLC). Intraperitoneal injection was done on the 18th day of pregnancy; the plasma and brains of the mother mice, placentae and the fetuses’ brains were dissected following 5, 15, 30, 60, and 120 min of treatment. Significant incorporation of K027 was found in the placentae and in fetuses’ brains relative to its levels in the mothers’ plasma and brains. This incorporation warns of a possible adjustment of dose of pyridinium aldoxime antidotes in case of pregnancy. Further studies with different gestational periods and animal models are warranted.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1]

    P. Aarseth and J.A. Barstad, Arch. Int. Pharmacodyn. Ther., 176, 434 (1986)

  • [2]

    A.W. Abu-Quare and M.B. Abou-Donia, J. Appl. Toxicol., 21, 307 (2001)

  • [3]

    G.A. Petroianu , K. Arafat, K. Kuca, and J. Kassa, J. Appl Toxicol., 26, 64 (2006)

  • [4]

    G.A. Petroianu, S.M. Nurulain, N. Nagelkerke, M.A. Al-Sultan, K. Kuca, and J. Kassa, J. Appl. Toxicol., 26, 262 (2006)

  • [5]

    G.A. Petroianu, M.Y. Hasan, S.M. Nurulain, N. Nagelkerke, J. Kassa, and K. Kuca, Toxicol. Mech. Methods, 17, 401 (2007)

  • [6]

    S.M. Nurulain, Trop. J. Pharm. Res., 10, 341 (2011)

  • [7]

    K. Kuca, J. Bielavsky, J. Cabal, and M. Bielavska, Tetrahedron Lett., 44, 3123 (2003)

  • [8]

    K. Kuca and J. Cabal, Cent. Eur. J. Public Health, 12 Suppl, S59 (2004)

  • [9]

    K. Kuca and J. Kassa, Vet. Hum. Toxicol., 46, 15 (2004)

  • [10]

    K. Kuca and J. Kassa, Hum. Exp. Toxicol., 23, 167 (2004)

  • [11]

    K. Kuca, L. Sevelová-Bartosová, and G. Krejcova-Kunesova, Acta Medica (Hradec Kralove), 47, 107 (2004)

  • [12]

    K. Kuca, J. Cabal, and J. Kassa, J. Toxicol. Environ. Health A, 68, 677 (2005)

  • [13]

    K. Kuca , K. Musilek, D. Jun, M. Pohanka, K.K. Ghosh, and M. Hrabinova, J. Enzyme Inhib. Med. Chem., 25, 509 (2010)

  • [14]

    J.Z. Karasova, J. Chladek, M. Hroch, F. Josef, D. Hnidkova, and K. Kuca, J. Appl. Toxicol., 33, 1823 (2013)

  • [15]

    J.Z. Karasova , F. Zemek, K. Musilek, and K. Kuca K. Neurotox. Res., 23, 63 (2013)

  • [16]

    H. Kalász, S.M. Nurulain, G. Veress, S. Antus, F. Darvas, E. Adeghate, A. Adem, F. Hashemi, and K. Tekes, J. Appl. Toxicol., 35, 116 (2015)

    • Search Google Scholar
    • Export Citation
  • [17]

    K. Tekes, M.Y. Hasan, R. Sheen, K. Kuca, G. Petroianu, K. Ludányi, and H. Kalász, J. Chromatogr. A., 1122, 84 (2006)

  • [18]

    M. Gyenge , H. Kalász, G.A. Petroianu, R. Laufer, K. Kuca, and K. Tekes, J. Chromatogr A., 1161, 146 (2007)

  • [19]

    T. Csermely, H. Kalász, G. Petroianu, K. Kuca, F. Darvas, K. Ludanyi, A.A. Mudhafar and K Tekes, K. Curr. Med. Chem., 15, 2401 (2008)

  • [20]

    H. Kalász, M.Y. Hasan, R. Sheen, K. Kuca, G. Petroianu, K. Ludányi, A. Gergely, and K. Tekes, Anal. Bioanal. Chem., 385, 1062 (2006)

  • [21]

    H. Kalász , J. Fürész, and K. Mini Rev. Med. Chem., 9, 596 (2009)

  • [22]

    H. Kalász, S.M. Nurulain, G. Veress, S. Antus, F. Darvas, E. Adeghate, A. Adem, F. Hashemi, and K. Tekes, J. Appl. Toxicol., 35, 116 (2015)

    • Search Google Scholar
    • Export Citation
  • [23]

    P. Szegi, H. Kalász, R. Laufer, K. Kuca, and K, Tekes, Anal. Bioanal. Chem., 397, 579 (2010)

  • [24]

    S. Ojha , S.M. Nurulain, S. Dhanasekaran, N. Nalin, A. Adem, C. Sharma, and H. Kalász, Blood-fetus penetration of pralidoxime, submitted for publication (2015)

    • Search Google Scholar
    • Export Citation
  • [25]

    S.M. Nurulain, K. Tekes, S.N.H. Naqvi, C. Sharma, and S. Ojha, Arch Toxicol., 88, 575 (2014)

  • [26]

    D.E. Lorke, M.Y. Hasan, S.M. Nurulain, R. Sheen, K. Kuca, and G.A. Petroianu, J. Appl. Toxicol., 27, 482 (2007)

  • [27]

    D.E. Lorke, H. Kalász, G. Petroianu, and K. Tekes, Curr. Med. Chem., 15, 743 (2008)

  • [28]

    D.E. Lorke, S.M. Nurulain, M.Y. Hasan, K. Kuca, K. Musilek, and G.A. Petroianu, J. Appl. Toxicol., 28, 920 (2008)

  • [29]

    S.M. Nurulain, H. Kalász, P. Szegi, K. Kuca, A. Adem, M.Y.B. Hasan, F. Hashemi, and K. Tekes, Acta Chromatogr., 25, 703 (2013)

  • [30]

    http://www.chemm.nlm.nih.gov/countermeasure_atropine-sulfate.htm

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Oct 2020 0 2 2
Nov 2020 0 5 5
Dec 2020 0 0 0
Jan 2021 0 3 1
Feb 2021 0 4 0
Mar 2021 0 2 1
Apr 2021 0 1 0